Remission Rates, Time to Remission, and Related Factors in Adolescents with Major Depressive Disorder

Topal Z., ÖZTÜRK Y., Demir N., Adiguzel O., KARADAĞ M., Tufan A. E.

EUROPEAN JOURNAL OF THERAPEUTICS, vol.27, no.3, pp.219-223, 2021 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.5152/eurjther.2021.20081
  • Journal Name: EUROPEAN JOURNAL OF THERAPEUTICS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.219-223
  • Keywords: Adolescent depression, treatment outcomes, remission, PLACEBO-CONTROLLED TRIAL, CHILDREN, FLUOXETINE, CHILDHOOD, SYMPTOMS, SCALE
  • Dokuz Eylül University Affiliated: No

Abstract

Objective: Major depressive disorder (MDD) is a common disorder in children and adolescents that can cause serious morbidity and mortality. Although response rates to treatment are high, less than half of the adolescents with MDD achieve remission. The present study aims to evaluate remission rates, time to remission, and the predictors of remission in adolescents with MDD.